Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Looks like standard filings--still have the 17th to accept mediation

RE: Looks like standard filings--still have the 17th to accept mediation

posted on Jul 12, 2006 10:06PM
July 17, 2006 Comply with P.R 3-1. P.R. 3-1 Disclosure of Asserted Claims and Preliminary Infringement Contentions.

Not later than 10 days after the Initial Case Management Conference, a party claiming patent

infringement must serve on all parties a “Disclosure of Asserted Claims and Preliminary

Infringement Contentions.” Separately for each opposing party, the “Disclosure of Asserted Claims

and Preliminary Infringement Contentions” shall contain the following information:

(a) Each claim of each patent in suit that is allegedly infringed by each opposing

party;

(b) Separately for each asserted claim, each accused apparatus, product, device,

process, method, act, or other instrumentality (“Accused Instrumentality”) of each

opposing party of which the party is aware. This identification shall be as specific

as possible. Each product, device, and apparatus must be identified by name or

model number, if known. Each method or process must be identified by name, if

known, or by any product, device, or apparatus which, when used

Share
New Message
Please login to post a reply